Company Profiles

driven by the PitchBook Platform

Milo Biotechnology

Milo Biotechnology
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE (In Progress)
$1.22M LATEST DEAL AMOUNT
$1.57M TOTAL AMOUNT RAISED
Description

Developer of gene therapies designed to increase muscle strength and prevent muscle atrophy. The company's gene therapies are based on a protein called follistatin that stimulates muscle growth and prevents muscle scarring after injury, enabling patients to achieve long lasting and potent expression in muscle.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Primary Office
11471 Euclid Avenue
Suite 214B
Cleveland, OH 44106
United States
+1 (216) 212-3211
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Milo Biotechnology’s full profile, request a free trial.

Milo Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 31-Oct-2016 $1.22M $1.57M In Progress Startup
3. Convertible Debt 05-Dec-2014 00000 00000 Completed Clinical Trials - Phase 2
2. Grant 25-Feb-2013 $300k $250k Completed Clinical Trials - Phase 1
1. Early Stage VC 14-Feb-2012 $250k $250k Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding request access »

Milo Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
JumpStart Venture Capital Minority 000 0000 000000 0
National Institute of Arthritis and Musculoskeletal and Skin Diseases Government 000 0000 000000 0
Rev1 Ventures Venture Capital Minority 000 0000 000000 0

Milo Biotechnology Executive Team (2)

Name Title Board
Seat
Contact
Info
Paul Hawkins Co-Founder, Manager, Chief Executive Officer & Board Member
Brian Kaspar Ph.D Co-Founder

Milo Biotechnology Board Members (1)

Name Representing Role Since Contact
Info
Paul Hawkins Milo Biotechnology Co-Founder, Manager, Chief Executive Officer & Board Member 000 0000